Literature DB >> 33796923

Advantageous Short-Term Outcomes of Esophagojejunostomy Using a Linear Stapler Following Open Total Gastrectomy Compared with a Circular Stapler.

Yusuke Muneoka1, Manabu Ohashi2, Rie Makuuchi1, Satoshi Ida1, Koshi Kumagai1, Takeshi Sano1, Souya Nunobe1.   

Abstract

BACKGROUND: Esophagojejunostomy is one of the most important surgical procedures in total gastrectomy. In the past, esophagojejunostomy was exclusively performed using a circular stapler in open total gastrectomy (OTG). With the increasing frequency of its use in laparoscopic gastrectomy, esophagojejunostomy using a linear stapler has been performed in OTG. However, it is still unclear whether the use of a linear stapler in esophagojejunostomy following OTG has any advantages compared with the conventional use of a circular stapler.
METHODS: A total of 298 patients who underwent OTG for gastric cancer between 2014 and 2019 were enrolled in this study. Patients were categorized into circular and linear groups (group C and group L) according to the stapler type used for the esophagojejunostomy. After propensity score matching, 136 patients (68 each in groups C and L) were selected to compare the surgical outcomes including incidence of esophagojejunostomy-related complications and postoperative nutritional status.
RESULTS: The median operation time was significantly longer in group L than in group C (261.5 min versus 325.5 min; P < 0.001). The incidence of esophagojejunostomy-related complications did not differ between the two groups (5.9% versus 2.9%; P = 0.68); however, no anastomotic stricture and bleeding occurred in group L. Bodyweight loss was significantly lower in group L than in group C at 6 months (15.9% versus 12.6%; P = 0.007) after surgery.
CONCLUSIONS: Esophagojejunostomy using a linear stapler following OTG is equally safe and possibly advantageous in anastomotic stricture, bleeding and nutritional status compared with the use of a circular stapler.

Entities:  

Year:  2021        PMID: 33796923     DOI: 10.1007/s00268-021-06100-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  8 in total

1.  Esophageal anastomosis following gastrectomy for gastric cancer: comparison of hand-sewn and stapling technique.

Authors:  I Takeyoshi; S Ohwada; T Ogawa; Y Kawashima; T Ohya; S Kawate; K Arai; Y Nakasone; Y Morishita
Journal:  Hepatogastroenterology       Date:  2000 Jul-Aug

2.  Stenosis of esophago-jejuno anastomosis after gastric surgery.

Authors:  Takeo Fukagawa; Takuji Gotoda; Ichiro Oda; Yasunori Deguchi; Makoto Saka; Shinji Morita; Hitoshi Katai
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

3.  Stapled sutures in digestive tract surgery.

Authors:  G Di Matteo; A Cancrini; G Palazzini; L Boemi
Journal:  Int Surg       Date:  1988 Jan-Mar

4.  Risk factors of esophagojejunal anastomotic leakage after total gastrectomy for gastric cancer.

Authors:  H Isozaki; K Okajima; T Ichinona; H Hara; K Fujii; E Nomura
Journal:  Hepatogastroenterology       Date:  1997 Sep-Oct

5.  Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome.

Authors:  Chris Deans; Matthew S W Yeo; Mu Yar Soe; Asim Shabbir; T K Ti; Jimmy B Y So
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

6.  Identification of risk factors for esophagojejunal anastomotic leakage after gastric surgery.

Authors:  Yasunori Deguchi; Takeo Fukagawa; Shinji Morita; Masaki Ohashi; Makoto Saka; Hitoshi Katai
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

7.  The predisposition to infection following hemorrhagic shock.

Authors:  B C Esrig; L Frazee; S F Stephenson; H C Polk; R L Fulton; C E Jones
Journal:  Surg Gynecol Obstet       Date:  1977-06

8.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.